Serum to start phase III trial in India after clearances

“Cadila and Bharat Biotech have completed phase I trials. Serum Institute has completed phase II-B3 trials and will begin phase III trial (with 1,500 patients at 14 locations) after authorizations,” said Balram Bhargava, DG. , ICMR. Phase I clinical trials have revealed “excellent safety” of the two candidate vaccines developed …

Read More »